At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors: A Randomized Clinical Pilot Trial
In Brief
A clinical study evaluating Acceptance and Commitment Therapy, Survivorship Education, and 1 other intervention for Breast Neoplasms and 16 related conditions. Completed, enrolled 91 participants across 1 site.
Detailed Summary
Fear of cancer recurrence (FCR) is one of the most prevalent, persistent, and disruptive sources of distress for adult cancer survivors. Prevalence rates for FCR have been estimated at up to 89%, with approximately half of cancer survivors reporting clinically significant levels of FCR. Despite the recognized prevalence, persistence, and suffering associated with FCR, effective and accessible treatments for FCR are lacking and urgently needed. Our long-term goal is to develop, evaluate, and implement effective behavioral interventions for cancer survivors suffering with FCR.
Study Details
Timeline
Interventions
6-week ACT intervention group (n=33)
6-week survivorship education group (SE; n=32)
enhanced usual care (EUC; n=26)